Los Angeles, CA - 
(NewMediaWire) - April 6, 2021 - The Schall Law Firm, a
national shareholder rights litigation firm, reminds investors of a class
action lawsuit against Athenex, Inc. (“Athenex” or “the Company”) (NASDAQ: ATNX)
for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and
Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
Commission.
Investors who purchased the
Company's securities between August 7, 2019 and February 26, 2021, inclusive
(the ''Class Period''), are encouraged to contact the firm before May 3,
2021.
If you are a shareholder who
suffered a loss, click here to participate.
We also encourage you to contact
Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los
Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You
can also reach us through the firm's website at www.schallfirm.com,
or by email at brian@schallfirm.com.
The class, in this case, has not
yet been certified, and until certification occurs, you are not represented by
an attorney. If you choose to take no action, you can remain an absent class
member.
According to the Complaint, the
Company made false and misleading statements to the market. Athenex announced
on March 1, 2021, that the FDA had issued a complete response letter (“CRL”)
for the company's New Drug Application (“NDA”) for oral paclitaxel plus
encequidar for the treatment of metastatic breast cancer. The FDA’s CRL cited
patient safety risks and uncertainty related to primary endpoint results for
the objective response rate (“ORR”) which may have introduced bias in the
blinded clinical review. The FDA recommended the Company “conduct a new
adequate and well-conducted clinical trial in a patient population with
metastatic breast cancer representative of the population in the U.S." The
FDA also indicated that the toxicity would require a risk mitigation strategy
for the treatment to be approved. Based on this news, shares of Athenex fell by
55% in one day.
Join the case to recover your losses.
The Schall Law Firm represents
investors around the world and specializes in securities class action lawsuits
and shareholder rights litigation.
This press release may be
considered Attorney Advertising in some jurisdictions under the applicable law
and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
SOURCE:
The Schall Law Firm
